Edition:
United States

Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

23.48USD
11 Dec 2018
Change (% chg)

-- (--)
Prev Close
$23.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
154,532
52-wk High
$46.12
52-wk Low
$19.72

Chart for

About

Audentes Therapeutics, Inc. is an early-stage biotechnology company. The Company is focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects. The Company has a portfolio of product candidates, including AT132 for the... (more)

Overall

Beta: --
Market Cap(Mil.): $1,004.49
Shares Outstanding(Mil.): 42.69
Dividend: --
Yield (%): --

Financials

  BOLD.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -2.72 -- --
ROI: -38.80 0.60 13.80
ROE: -40.36 -2.18 15.29

Earnings vs. Estimates